Studies have confirmed PD1 can activate intracellular signaling pathways to inhibit the activation of immune cells or exhaust the immune cell, especially activated T cells in tumor condition to help cancer cells escape T-cell-mediated death and resist anti-tumor immune responses8. The gene discussed is PDCD1; the disease is cancer.